These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11585716)

  • 1. Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics.
    Moritz S; Andresen B; Jacobsen D; Mersmann K; Wilke U; Lambert M; Naber D; Krausz M
    Eur Psychiatry; 2001 Sep; 16(6):354-61. PubMed ID: 11585716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia.
    Cuesta MJ; Peralta V
    Psychiatry Res; 1995 Oct; 58(3):227-35. PubMed ID: 8570778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three syndrome concept of schizophrenia. A factor analytic study.
    Malla AK; Norman RM; Williamson P; Cortese L; Diaz F
    Schizophr Res; 1993 Aug; 10(2):143-50. PubMed ID: 8398946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.
    Rossi A; Mancini F; Stratta P; Mattei P; Gismondi R; Pozzi F; Casacchia M
    Acta Psychiatr Scand; 1997 Jan; 95(1):40-3. PubMed ID: 9051159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theory of mind in schizophrenia: the role of clinical symptomatology and neurocognition in understanding other people's thoughts and intentions.
    Abdel-Hamid M; Lehmkämper C; Sonntag C; Juckel G; Daum I; Brüne M
    Psychiatry Res; 2009 Jan; 165(1-2):19-26. PubMed ID: 19073346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of dimensions of psychopathology in neuroleptic-naïve patients with recent-onset schizophrenia/schizophreniform disorder.
    John JP; Khanna S; Thennarasu K; Reddy S
    Psychiatry Res; 2003 Nov; 121(1):11-20. PubMed ID: 14572620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics.
    Rollnik JD; Borsutzky M; Huber TJ; Mogk H; Seifert J; Emrich HM; Schneider U
    Neuropsychobiology; 2002; 45(2):74-80. PubMed ID: 11893863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom segregation in chronic schizophrenia: the significance of thought disorder.
    Sarai M; Matsunaga H
    Schizophr Res; 1993 Aug; 10(2):159-63. PubMed ID: 8398948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficit symptoms in schizophrenia: negative symptoms versus neuroleptic-induced deficits.
    Schooler NR
    Acta Psychiatr Scand Suppl; 1994; 380():21-6. PubMed ID: 7914043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling cognitive impairment in treatment-resistant schizophrenia patients.
    Frydecka D; Beszłej JA; Gościmski P; Kiejna A; Misiak B
    Psychiatry Res; 2016 Jan; 235():133-8. PubMed ID: 26706131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment in test performance and symptom dimensions of schizophrenia.
    Eckman PS; Shean GD
    J Psychiatr Res; 2000; 34(2):147-53. PubMed ID: 10758257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative and deficit symptoms in schizophrenia do respond to neuroleptics.
    Goldberg SC
    Schizophr Bull; 1985; 11(3):453-6. PubMed ID: 2863872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs for the treatment of schizophrenic patients.
    Fleischhacker WW
    Acta Psychiatr Scand Suppl; 1995; 388():24-30. PubMed ID: 7604735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive inhibition and schizophrenic symptom subgroups.
    Williams LM
    Schizophr Bull; 1996; 22(1):139-51. PubMed ID: 8685656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of neuroleptics on specific syndromes and symptoms in schizophrenics with unfavourable long-term course. A 5-year follow-up study of 50 chronic schizophrenics.
    Beckmann H; Fritze J; Franzek E
    Neuropsychobiology; 1992; 26(1-2):50-8. PubMed ID: 1361971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological considerations regarding the association of Stroop and verbal fluency performance with the symptoms of schizophrenia.
    Woodward TS; Ruff CC; Thornton AE; Moritz S; Liddle PF
    Schizophr Res; 2003 Jun; 61(2-3):207-14. PubMed ID: 12729872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and psychophysiological correlates of positive, negative, and disorganized symptoms in the schizophrenia spectrum.
    Brekke JS; Raine A; Thomson C
    Psychiatry Res; 1995 Aug; 57(3):241-50. PubMed ID: 7501734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
    Rémillard S; Pourcher E; Cohen H
    J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing declarative memory in schizophrenia using Wisconsin Card Sorting Test stimuli: the Paired Associate Recognition Test.
    Ragland JD; Censits DM; Gur RC; Glahn DC; Gallacher F; Gur RE
    Psychiatry Res; 1996 Mar; 60(2-3):135-45. PubMed ID: 8723304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.